We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
-12.03%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.12B
AUM Growth
-$213M
Cap. Flow
-$46.9M
Cap. Flow %
-4.17%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
3
Closed
–

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$22.5M

Top Sells

Rank Stock Value
1
MNST icon
Monster Beverage
MNST
+$46.1M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$23.3M
3
IMDX
Insight Molecular Diagnostics
IMDX
+$4

Sector Composition

Rank Sector Weight
1 Consumer Staples 40.02%
2 Healthcare 37.64%
3 Industrials 13.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$450M 40.02%
8,501,236
-811,740
-9% -$46.1M
STAA icon
2
STAAR Surgical
STAA
$1.21B
$372M 33.1%
9,264,427
+481,345
+5% +$22.5M
AXON
3
Axon Enterprise
AXON
$42.5B
$151M 13.45%
760,062
– –
IWM icon
4
iShares Russell 2000 ETF
IWM
$79.8B
$100M 8.89%
566,000
-124,000
-18% -$23.3M
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$41.2M 3.67%
34,935,485
– –
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$7.83M 0.7%
2,509,066
-1
-0% -$4
SER icon
7
Serina Therapeutics
SER
$30M
$2.04M 0.18%
85,219
– –

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Broadwood Capital held 7 positions worth $1.12B, down 16% from $1.34B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital withdrew a net $46.9M in Q3 2023, reducing 3 holdings. Its largest reduction was Monster Beverage, cutting an estimated $46.1M.

By sector, the portfolio is most concentrated in Consumer Staples at 40% of assets, up from 40% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Broadwood Capital added an estimated $22.5M to STAAR Surgical.

  • Broadwood Capital added most to STAAR Surgical in Q3 2023, an estimated $22.5M increase.
  • Broadwood Capital's biggest Q3 2023 reduction was Monster Beverage, cutting an estimated $46.1M.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.12B portfolio in Q3 2023.
  • Broadwood Capital opened 0 new positions and closed 0 in Q3 2023.
  • Broadwood Capital's portfolio value fell 16% quarter-over-quarter to $1.12B.

Based on Broadwood Capital's 13F filing for Q3 2023, filed 14 Nov 2023.